![Deirdre Gillespie](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Deirdre Gillespie
Directeur Général chez
IRAD Oncology, Inc.
Profil
Deirdre Y.
Gillespie currently works at IRAD Oncology, Inc., as Chief Executive Officer from 2013.
Dr. Gillespie also formerly worked at La Jolla Pharmaceutical Co., as President, Chief Executive Officer & Director from 2011 to 2012, Oxxon Therapeutics, Inc., as President & Chief Executive Officer from 2001 to 2005, Virttu Biologics Ltd., as Chief Executive Officer, Apricus Biosciences, Inc., as Independent Director from 2010 to 2016, Vical, Inc., as Chief Operating Officer from 1998 to 2001, and DuPont Merck Pharmaceutical Co., as Vice President-Marketing from 1991 to 1996.
Dr. Gillespie received her undergraduate degree and doctorate degree from the University of London and Masters Business Admin degree from London Business School.
Postes actifs de Deirdre Gillespie
| Sociétés | Poste | Début |
|---|---|---|
IRAD Oncology, Inc. | Directeur Général | 01/01/2013 |
Anciens postes connus de Deirdre Gillespie
| Sociétés | Poste | Fin |
|---|---|---|
Apricus Biosciences, Inc.
 Apricus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Designs, develops and commercialises therapeutic products | Directeur/Membre du Conseil | 05/04/2016 |
| LA JOLLA PHARMACEUTICAL COMPANY | Directeur Général | 19/01/2012 |
Oxxon Therapeutics, Inc.
 Oxxon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures antigen-specific immunotherapy’s to treat patients | President | 01/01/2005 |
Vical, Inc.
 Vical, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Directeur des opérations | 01/01/2001 |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Makes pharmaceuticals and drugs | Sales & Marketing | 01/01/1996 |
Formation de Deirdre Gillespie
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
57
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
La Jolla Pharmaceutical Co.
 La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes patients life-threatening conditions | Health Technology |
Apricus Biosciences, Inc.
Apricus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Designs, develops and commercialises therapeutic products | Health Technology |
DuPont Merck Pharmaceutical Co.
DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Makes pharmaceuticals and drugs | Health Technology |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oxxon Therapeutics, Inc.
Oxxon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures antigen-specific immunotherapy’s to treat patients | Health Technology |
London Business School
 London Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IRAD Oncology, Inc. | |
Virttu Biologics Ltd.
 Virttu Biologics Ltd. Pharmaceuticals: OtherHealth Technology Develops oncolytic virus therapy for treatment of cancer | Health Technology |
